Association of British HealthTech Industries

Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer

Retrieved on: 
Thursday, October 19, 2023

Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces the appointment of Martin Walton as Chief Financial Officer.

Key Points: 
  • Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces the appointment of Martin Walton as Chief Financial Officer.
  • Since 2009, Martin has been an active Venture Capital and Private Equity investor, portfolio manager, and advisor in life sciences working with several of the largest investors in the sector.
  • Robin Bhattacherjee, Actimed CEO, commented: “I am delighted to welcome Martin to Actimed, who brings with him a set of highly complementary skills and extensive industry experience.
  • Martin Walton, Actimed CFO commented: “I am excited to be joining Actimed at this important point in the company’s journey to develop the first globally approved product for cancer cachexia.

Phenology's Menopause Study Unveils Key Insights for Transformative Innovation

Retrieved on: 
Wednesday, October 25, 2023

The study findings paint a vivid picture of the diverse experiences women have of this complex transition and reveal new insights that can transform care.

Key Points: 
  • The study findings paint a vivid picture of the diverse experiences women have of this complex transition and reveal new insights that can transform care.
  • View the full release here: https://www.businesswire.com/news/home/20231025455346/en/
    A random sample of 200 women in the study illustrates the variation of menopause symptom signatures.
  • (Graphic: Business Wire)
    Most astonishing was the discovery of more than 15,000 unique menopause symptom signatures in the data set.
  • Releasing this study underscores the brand's dedication to enhancing the scientific understanding of menopause, paving the way for meaningful innovation.

72% of consumers are apprehensive about the potential misuse of their health information by external entities

Retrieved on: 
Tuesday, October 24, 2023

WARRINGTON, England, Oct. 24, 2023 /PRNewswire/ -- Today Cassie, the consent management platform serving Fortune 500 companies globally, unveiled a new research report about consumer's level of uncertainty with consent and data management within the U.S. healthcare system. Cassie's new Prescribing Privacy Healthcare Report, which surveyed more than 800 U.S. consumers, found the majority concern for consumers with modern healthcare data practices is the lack of informed consent. Transparency and trust were noted to be a high priority when sharing data for consumers in addition to better patient education surrounding healthcare data privacy practices.

Key Points: 
  • Transparency and trust were noted to be a high priority when sharing data for consumers in addition to better patient education surrounding healthcare data privacy practices.
  • In the age of technology, healthcare providers are facing a critical challenge: gaining the trust of consumers who are increasingly concerned about protecting their data privacy.
  • Notably, Cassie research reveals that 50% of consumers trust tech companies more than healthcare providers to protect their data, underscoring a concerning trend.
  • Data breaches, healthcare mergers and acquisitions and the continued integration of healthtech in patient services are becoming all too common, putting patients' information at risk.

72% of consumers are apprehensive about the potential misuse of their health information by external entities

Retrieved on: 
Tuesday, October 24, 2023

WARRINGTON, England, Oct. 24, 2023 /PRNewswire/ -- Today Cassie, the consent management platform serving Fortune 500 companies globally, unveiled a new research report about consumer's level of uncertainty with consent and data management within the U.S. healthcare system. Cassie's new Prescribing Privacy Healthcare Report, which surveyed more than 800 U.S. consumers, found the majority concern for consumers with modern healthcare data practices is the lack of informed consent. Transparency and trust were noted to be a high priority when sharing data for consumers in addition to better patient education surrounding healthcare data privacy practices.

Key Points: 
  • Transparency and trust were noted to be a high priority when sharing data for consumers in addition to better patient education surrounding healthcare data privacy practices.
  • In the age of technology, healthcare providers are facing a critical challenge: gaining the trust of consumers who are increasingly concerned about protecting their data privacy.
  • Notably, Cassie research reveals that 50% of consumers trust tech companies more than healthcare providers to protect their data, underscoring a concerning trend.
  • Data breaches, healthcare mergers and acquisitions and the continued integration of healthtech in patient services are becoming all too common, putting patients' information at risk.

MAOR INVESTMENTS Announces the Closing of Its Second Fund at $180M, 1.8x the Size of MAOR I

Retrieved on: 
Friday, October 20, 2023

MAOR INVESTMENTS, a Luxembourg-based venture capital fund dedicated to Israeli technologies, is proud to announce the final closing of its second fund, MAOR II, at $180 million.

Key Points: 
  • MAOR INVESTMENTS, a Luxembourg-based venture capital fund dedicated to Israeli technologies, is proud to announce the final closing of its second fund, MAOR II, at $180 million.
  • This access emphasizes the differentiating positioning of the fund as « Bridge to Europe », reflecting MAOR INVESTMENTS’ unique value in the Israeli ecosystem.
  • By aligning its investments with ESG criteria and signing the Principles for Responsible Investment (PRI) for MAOR II, an Article 8 SFDR fund, MAOR INVESTMENTS is committed to investing responsibly.
  • The MAOR INVESTMENTS team sincerely thanks its investors, portfolio companies, team members and corporate partners for their precious support and collaboration.

Accredify from Singapore beats 260 startups to win the 2023 Supernova Challenge

Retrieved on: 
Thursday, October 19, 2023

DUBAI, UAE, Oct. 19, 2023 /PRNewswire/ -- Accredify, a Singapore-based startup and service provider for issuing verifiable documents and information, has emerged as the champion of the 2023 Supernova Challenge at Expand North Star Dubai, the world's largest startup event. The startup received the $100,000 grand prize after an intense final round of pitching against 27 global finalists from 521 entries.

Key Points: 
  • The Supernova Challenge in partnership with the Dubai Future District Fund, is the region's biggest startup pitch competition, offering $200,000 in total cash prizes.
  • It attracted over 1800+ startups from over 100 countries to explore the emerging opportunities in Dubai's dynamic, diverse and tech-driven digital economy.
  • Simon Gordon, Chief Commercial Officer of the winning team, said, "Supernova 2023 has been an incredible experience.
  • The pitches we witnessed here at the Supernova Challenge are brimming with promise, unique innovations, and inspiring ideas."

Accredify from Singapore beats 260 startups to win the 2023 Supernova Challenge

Retrieved on: 
Thursday, October 19, 2023

DUBAI, UAE, Oct. 19, 2023 /PRNewswire/ -- Accredify, a Singapore-based startup and service provider for issuing verifiable documents and information, has emerged as the champion of the 2023 Supernova Challenge at Expand North Star Dubai, the world's largest startup event. The startup received the $100,000 grand prize after an intense final round of pitching against 27 global finalists from 521 entries.

Key Points: 
  • The Supernova Challenge in partnership with the Dubai Future District Fund, is the region's biggest startup pitch competition, offering $200,000 in total cash prizes.
  • It attracted over 1800+ startups from over 100 countries to explore the emerging opportunities in Dubai's dynamic, diverse and tech-driven digital economy.
  • Simon Gordon, Chief Commercial Officer of the winning team, said, "Supernova 2023 has been an incredible experience.
  • The pitches we witnessed here at the Supernova Challenge are brimming with promise, unique innovations, and inspiring ideas."

ibex Wins 2023 TITAN Award for Most Innovative Company of the Year

Retrieved on: 
Tuesday, October 17, 2023

WASHINGTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that it has won the prestigious Platinum 2023 TITAN Business Award for Most Innovative Company of the Year.

Key Points: 
  • WASHINGTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that it has won the prestigious Platinum 2023 TITAN Business Award for Most Innovative Company of the Year.
  • “ibex is proud to receive the TITAN Platinum Award for Most Innovative Company of 2023,” said ibex CEO Bob Dechant.
  • “We have a strong heritage of driving innovation in the CX space and continue to pioneer new and exciting solutions.
  • In addition to the Most Innovative Company of the Year award, ibex Chief Strategic Accounts Officer and CMO Julie Casteel was recognized as Female Executive of the Year – Marketing, by the TITAN Women in Business Awards .

Notable Labs Closes Merger Transaction With VBL Therapeutics

Retrieved on: 
Monday, October 16, 2023

- Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund -

Key Points: 
  • - Completed previously announced $10.3 million private placement with leading healthtech-focused investors, led by Builders VC, B Capital Group, Y Combinator, First Round Capital, and Founders Fund -
    FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced the completion of its merger transaction with VBL Therapeutics (“VBL”) (Nasdaq: VBLT) and associated financing.
  • “This is an important milestone for Notable as we continue to advance the demonstrated value of the PPMP,” said Thomas Bock, M.D., Chief Executive Officer of Notable.
  • “The merger will add additional capital to accelerate our continued development of Volasertib for the treatment of AML in PPMP-predicted responding patients.
  • PPMP has guided Notable in the selection and development of two clinical-stage therapeutic candidates in platform-predicted responding patients with AML.

eMerge Americas Celebrates 10 Years of Cultivating Innovation and Transformation

Retrieved on: 
Tuesday, October 10, 2023

MIAMI, Oct. 10, 2023 /PRNewswire/ -- eMerge Americas, the premier global tech event held annually in Miami, proudly celebrates a decade of transformational work shaping the future of tech and innovation. eMerge Americas 2024 is gearing up to be the biggest and best conference + expo in the company's history. The event will take place at the Miami Beach Convention Center on April 18 - 19, 2024.

Key Points: 
  • MIAMI, Oct. 10, 2023 /PRNewswire/ -- eMerge Americas , the premier global tech event held annually in Miami, proudly celebrates a decade of transformational work shaping the future of tech and innovation.
  • eMerge Americas 2024 is gearing up to be the biggest and best conference + expo in the company's history.
  • "eMerge is a true reflection of the amazing growth our region's tech ecosystem has experienced over the last decade.
  • "Celebrating ten years of eMerge Americas is a testament to the hardwork and dedication of the team and the entire South Florida ecosystem," said Manuel D. Medina, founder and chairman of eMerge Americas.